Cargando…
Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine
INTRODUCTION: Present investigation describes an influence of ratio of Gelucire 43/01(hydrophobic) to hydroxypropyl methylcellulose K4M (HPMC K4M) (hydrophilic) and different fillers on release of famotidine from gastro-retentive tablets using 3(2) full factorial design. Ratio of Gelucire 43/01 to H...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465142/ https://www.ncbi.nlm.nih.gov/pubmed/23071951 http://dx.doi.org/10.4103/2230-973X.93006 |
_version_ | 1782245514169810944 |
---|---|
author | Patel, Dasharath M Patel, Mehul J Patel, Ankit N Patel, Chhagan N |
author_facet | Patel, Dasharath M Patel, Mehul J Patel, Ankit N Patel, Chhagan N |
author_sort | Patel, Dasharath M |
collection | PubMed |
description | INTRODUCTION: Present investigation describes an influence of ratio of Gelucire 43/01(hydrophobic) to hydroxypropyl methylcellulose K4M (HPMC K4M) (hydrophilic) and different fillers on release of famotidine from gastro-retentive tablets using 3(2) full factorial design. Ratio of Gelucire 43/01 to HPMC K4M (X(1)) and the type of filler (X(2)) were selected as independent variables while buoyancy lag time (BLT), drug release at 1h (Q(1)), 6h (Q(6)), and the 12h (Q(12)) were selected as dependent variables. MATERIALS AND METHODS: Gastro-retentive tablets of famotidine were prepared by a solvent free melt granulation technique using Gelucire 43/01 as a hydrophobic meltable binder. HPMC K4M and sodium bicarbonate were used as matrixing agent and gas-generating agent, respectively. Prepared tablets were evaluated for in vitro dissolution, in vitro buoyancy, friability, hardness, drug content and weight variation. Dissolution data were fitted to various models to ascertain kinetics of drug release. The data were analyzed using regression analysis and analysis of variance. RESULTS: All formulations (F(1)-F(9)) showed floating within 3min and had total floating time of more than 12h. It was observed that a type of filler and the ratio of Gelucire 43/01 to HPMC K4M had significant influence on buoyancy lag time (P = 0.037) and Q(6) (P = 0.011), respectively without significant influence on Q(1) and Q(12). CONCLUSION: Formulation F(5) was selected as an optimum formulation as it showed more similarity in dissolution profile with theoretical profile (Similarity factor, f(2) = 83.01). The dissolution of batch F(5) can be described by zero order kinetics (r(2) = 0.9914) with anomalous (non-Fickian) diffusion as a release mechanism (n = 0.559). The difference observed in in vitro release profile after temperature sensitivity study at 40°C for 1 month was insignificant. |
format | Online Article Text |
id | pubmed-3465142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-34651422012-10-15 Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine Patel, Dasharath M Patel, Mehul J Patel, Ankit N Patel, Chhagan N Int J Pharm Investig Original Research Article INTRODUCTION: Present investigation describes an influence of ratio of Gelucire 43/01(hydrophobic) to hydroxypropyl methylcellulose K4M (HPMC K4M) (hydrophilic) and different fillers on release of famotidine from gastro-retentive tablets using 3(2) full factorial design. Ratio of Gelucire 43/01 to HPMC K4M (X(1)) and the type of filler (X(2)) were selected as independent variables while buoyancy lag time (BLT), drug release at 1h (Q(1)), 6h (Q(6)), and the 12h (Q(12)) were selected as dependent variables. MATERIALS AND METHODS: Gastro-retentive tablets of famotidine were prepared by a solvent free melt granulation technique using Gelucire 43/01 as a hydrophobic meltable binder. HPMC K4M and sodium bicarbonate were used as matrixing agent and gas-generating agent, respectively. Prepared tablets were evaluated for in vitro dissolution, in vitro buoyancy, friability, hardness, drug content and weight variation. Dissolution data were fitted to various models to ascertain kinetics of drug release. The data were analyzed using regression analysis and analysis of variance. RESULTS: All formulations (F(1)-F(9)) showed floating within 3min and had total floating time of more than 12h. It was observed that a type of filler and the ratio of Gelucire 43/01 to HPMC K4M had significant influence on buoyancy lag time (P = 0.037) and Q(6) (P = 0.011), respectively without significant influence on Q(1) and Q(12). CONCLUSION: Formulation F(5) was selected as an optimum formulation as it showed more similarity in dissolution profile with theoretical profile (Similarity factor, f(2) = 83.01). The dissolution of batch F(5) can be described by zero order kinetics (r(2) = 0.9914) with anomalous (non-Fickian) diffusion as a release mechanism (n = 0.559). The difference observed in in vitro release profile after temperature sensitivity study at 40°C for 1 month was insignificant. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3465142/ /pubmed/23071951 http://dx.doi.org/10.4103/2230-973X.93006 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Patel, Dasharath M Patel, Mehul J Patel, Ankit N Patel, Chhagan N Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title | Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title_full | Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title_fullStr | Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title_full_unstemmed | Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title_short | Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
title_sort | formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465142/ https://www.ncbi.nlm.nih.gov/pubmed/23071951 http://dx.doi.org/10.4103/2230-973X.93006 |
work_keys_str_mv | AT pateldasharathm formulationandevaluationofmixedmatrixgastroretentivedrugdeliveryforfamotidine AT patelmehulj formulationandevaluationofmixedmatrixgastroretentivedrugdeliveryforfamotidine AT patelankitn formulationandevaluationofmixedmatrixgastroretentivedrugdeliveryforfamotidine AT patelchhagann formulationandevaluationofmixedmatrixgastroretentivedrugdeliveryforfamotidine |